Comparing Lo Loestrin Fe vs Mili
Lo Loestrin Fe (ethinyl estradiol / norethindrone) | Mili (ethinyl estradiol / norgestimate) |
|
---|
Lo Loestrin Fe (ethinyl estradiol / norethindrone) | Mili (ethinyl estradiol / norgestimate) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Birth Control. Lo Loestrin Fe may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Birth Control. Mili may also be used for purposes not listed in this medication guide. |
Related suggestions |
|||||||||||||||
More about Lo Loestrin Fe (ethinyl estradiol / norethindrone) | More about Mili (ethinyl estradiol / norgestimate) | ||||||||||||||||
Ratings & Reviews | |||||||||||||||||
Lo Loestrin Fe has an average rating of 5.7 out of 10 from a total of 1558 ratings on Drugs.com. 42% of reviewers reported a positive effect, while 37% reported a negative effect. |
Mili has an average rating of 3.9 out of 10 from a total of 264 ratings on Drugs.com. 27% of reviewers reported a positive effect, while 64% reported a negative effect. |
||||||||||||||||
Drug Class | |||||||||||||||||
Side Effects | |||||||||||||||||
Generic Availability | |||||||||||||||||
Lower cost generic approved | |||||||||||||||||
Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Lo Loestrin Fe prices |
View all Mili prices |
||||||||||||||||
Dosage Forms Available | |||||||||||||||||
|
|
||||||||||||||||
Brand Names | |||||||||||||||||
Other ethinyl estradiol / norethindrone brands include: Alyacen 1/35, Alyacen 7/7/7, Aranelle, Aurovela 1.5/30, Aurovela 1/20, Aurovela 24 Fe, Aurovela Fe 1.5/30, Aurovela Fe 1/20, Balziva, Blisovi 24 Fe, Blisovi Fe 1.5/30, Blisovi Fe 1/20, Brevicon, Briellyn, Chabelina Fe, Charlotte 24 Fe, Cyclafem 0.5/35, Cyclafem 1/35, Cyclafem 7/7/7, Cyonanz, Dasetta, Dasetta 1/35, Dasetta 7/7/7, Estrostep Fe, Femcon Fe, femhrt, Femlyv, Finzala, Fyavolv, Gemmily, Generess Fe, Gildagia, Gildess 1.5/30, Gildess 1/20, Gildess 24 Fe, Gildess Fe 1.5/30, Gildess Fe 1/20, Hailey 1.5/30, Hailey 24 Fe, Hailey Fe 1.5/30, Hailey Fe 1/20, Jinteli, Junel 1.5/30, Junel 1/20, Junel Fe 1.5/30, Junel Fe 1/20, Junel Fe 24, Kaitlib Fe, Larin 1.5/30, Larin 1/20, Larin 24 Fe, Larin Fe 1.5/30, Larin Fe 1/20, Layolis Fe, Leena, Leribane, Loestrin 21 1/20, Lomedia 24 Fe, Melodetta 24 Fe, Merzee, Mibelas 24 Fe, Microgestin 1.5/30, Microgestin 1/20, Microgestin Fe 1.5/30, Microgestin Fe 1/20, Minastrin 24 Fe, Necon 0.5/35, Necon 7/7/7, Nexesta Fe, Norinyl 1+35, Nortrel 0.5/35, Nortrel 1/35, Nortrel 7/7/7, Nylia 1/35, Nylia 7/7/7, Ortho-Novum 7/7/7, Oshih, Philith, Pirmella 1/35, Pirmella 7/7/7, Rhuzdah, Tarina 24 Fe, Tarina Fe 1/20, Taysofy, Taytulla, Tilia Fe, Tri-Legest, Tri-Legest Fe, Vyfemla, Wera, Wymzya Fe, Zenchent, Zenchent Fe View more | Other ethinyl estradiol / norgestimate brands include: Estarylla, Femynor, Mono-Linyah, Nymyo, Previfem, Sprintec, Tri Femynor, Tri-Estarylla, Tri-Linyah, Tri-Lo-Estarylla, Tri-Lo-Linyah, Tri-Lo-Marzia, Tri-Lo-Mili, Tri-Lo-Sprintec, Tri-Mili, Tri-Nymyo, Tri-Previfem, Tri-Sprintec, Tri-VyLibra, Tri-Vylibra Lo, VyLibra View more | ||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||||||||||
14 hours |
N/A |
||||||||||||||||
CSA Schedule ** View glossary of terms | |||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | |||||||||||||||||
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | |||||||||||||||||
A total of 471 drugs are known to interact with Lo Loestrin Fe:
|
A total of 468 drugs are known to interact with Mili:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
Disease Interactions | |||||||||||||||||
|
|
||||||||||||||||
First Approval Date | |||||||||||||||||
October 21, 2010 |
N/A |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||||||||||
N/A |
N/A |
||||||||||||||||
More Information | |||||||||||||||||
Patient resources | |||||||||||||||||
Professional Resources | |||||||||||||||||
Related Treatment Guide | |||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.